GBA Group Pharma

Your Challenges Require Smart Solutions


One of Europe’s largest and most experienced service providers

GBA Group Pharma is a member of the GBA Group and a unique service provider for the international pharmaceutical and biotech industry, with six locations across Austria and Germany. The well-known companies Pharmacelsus, GBA Pharma Labs, LKF Central Laboratory and ABF Pharmaceutical Services operate under the roof of GBA Group Pharma.

From early lead optimization and early preclinical stage to global clinical studies, we support clients throughout the entire lifecycle with our worldwide acting central laboratory, GMP depots, EU GMP manufacturing site for labeling and packaging and QP services, as well as late drug development and analytical services including import testing and QP batch release.

GBA Group Pharma is one of Europe’s largest and most experienced service providers for the pharmaceutical and biotech sector and has a total of 400 employees in Austria, Germany and the UK.


Expanded Range of COVID-19 Testing Methods for Clinical Trials Announced

ABF Pharmaceutical Services GmbH has been classified as "critical infrastructure" by the Federal Chancellery of Austria. This is based on the EU Directive 2008/114/EC, which defines the criteria according to which such infrastructure is identified and designated - namely, when a facility or part of a facility is "essential for maintaining important societal functions, health, safety, security and the economic or social well-being of the population and the disruption or destruction of which would have a significant impact because its functions could not be maintained". On the basis of this guideline, the Federal Chancellery and the Ministry of the Interior have drawn up a master plan for 2014 to ensure security of supply in key areas of society. The importance of ABF for the possibility of conducting clinical studies has now led to such a classification.


Brexit Safe Haven

We at GBA Group Pharma are one of a few vendors in the area of QP release, import into Europe as well as batch release testing that can grant CTSM (clinical trial supply management) and commercial supply after Brexit without any implications on our clients.

New GMP facilities for CTSM and commercials in Vienna place the company in a unique position as EMA clearly states that GMP depots, QP release activities and GMP testing must be located in the EU. The growth in size and service offerings will make GBA Group Pharma one of only a few companies able to offer a Brexit Proof Solution to the pharmaceutical industry.

EMA specifies clear regulations for medicines manufactured in the EU. When UK leaves the EU, GBA Group Pharma will be one of the few service providers in the EU which can meet this criteria
Elisabeth Lackner, CEO ABF & GBA Group Pharma

Join us on LinkedIn


Follow us on Twitter


Your contact for pharmaceutical services

We are happy to answer any questions you might have about our services!

GBA Group Sites

Sites – Food

How to reach us

We offer numerous locations and departments in Germany and Europe, so that you always have a reliable contact in your area.

Central Laboratory

Laboratorium für Klinische Forschung (LKF)

Site Page
Lise-Meitner-Str. 25-29
24223 Schwentinental

Tel. +49 4307 8276-0
Fax +49 4307 8276-79

Preclinical Services

Pharmacelsus GmbH

Site Page
Science Park 2
66123 Saarbrücken

Tel. +49 681 3946 - 7510
Fax +49 681 3946 - 7511

GMP Testing


Site Page
Am Haag 4
82166 Gräfelfing

Tel. +49 89 899229-104
Fax +49 89 899229-228

GMP Testing


Site Page
Ernst-Abbe-Straße 40
89079 Ulm

Tel. +49 731 97439-0
Fax +49 731 97439-30

GMP Testing


Site Page
Fraunhoferstraße 11a
82152 Martinsried

Tel. +49 89 899229-0
Fax +49 89 8577899

Clinical Trial Supply

ABF Pharmaceutical Services GmbH

Site Page
Brunner Strasse 63/18-19
1230 Wien

Tel. +43 1 8901200
Fax +43 1 8901200-11
© 2020 GBA Group
Data PrivacyLegal NoticeTerms& ConditionsDisclosure